How to Cite
Abstract
Cancer stem cells may be a source of malignant tumors as well as their relapses after treatment and metastases. They share many features with normal tissue stem cells but also possess mutations and other genetic and epigenetic changes that make them tumorigenic and resistant to conventional cancer therapies. The source of cancer stem cells is discussed: they may originate from normal tissue stem cells as a result of their mutations or deregulation of signaling pathways or alternatively from differentiated tumor cells as a result of dedifferentiation during tumor development. Cancer stem cells reside in a special tumor microenvironment (niche) that regulates their functions. A number of signaling pathways and molecules participate in regulating cancer stem cells features. And although there are some inconsistencies concerning cancer stem cells, their existence may change our view on cancer progression and help to develop new strategies of cancer treatment.References
Adams J. M., Strasser A. Is Tumor Growth Sustained by Rare Cancer Stem Cells or Dominant Clones? // Cancer Res. - 2008. - Vol. 68. - N. 11. - P 4018 - 4021.
Bao B., Ahmad A., Li Y et al. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells // Expert Opin Ther Targets. - 2012. - Vol. 16. - N. 10. - P. 1041 - 1054.
Bolos V., Blanco M., Medina V. et al. Notch signalling in cancer stem cells // Clin Transl Oncol. - 2009. - Vol.
- N. 1. - P. 11 - 19.
Bonnet D., Dick J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell // Nat Med. - 1997. - Vol. 3. - N. 7. - P 730 - 737.
Bussolati B., Dekel B., Azzarone B., Camussi G. Human renal cancer stem cells // Cancer Lett. - 2013. - Vol. 338. - N. 1. - P. 141 - 146.
Cabanillas R, Llorente J.L. The Stem Cell Network model: clinical implications in cancer // Eur Arch Otorhinolaryn-gol. - 2009. - Vol. 266. - N. 2. - P. 161-170.
Celia-Terrassa T., Meca-Cortes O., Mateo F. et al. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells // J Clin Invest. - 2012. - Vol. 122. - N. 5. - P 1849-1868.
Chang J. T., Mani S. A. Sheep, Wolf, or Werewolf: Cancer stem Cells and the Epithelial-to-Mesenchymal Transition // Cancer Lett. - 2013. - Vol. 341. - N. 1. - P. 16-23.
Chen K., Huang Y-H., Chen J-I. Understanding and targeting cancer stem cells: therapeutic implications and challenges // Acta Pharmacologica Sinica. - 2013. - Vol. 34. - P. 732-740.
Chui M. H. Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step // Int J Cancer. - 2013. - Vol. 132. - N. 7. - P. 1487-1495.
Clarke M. F., Dick J. E., Dirks P. B. et al. Cancer Stem Cells - Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells // Cancer Res. - 2006. - Vol. 66. - P. 9339-9344.
Creighton C. J., Chang J. C., Rosen J. M. Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer // J Mammary Gland Biol Neoplasia. - 2010. - Vol. 15. - P. 253-260.
Crowe D. L., Parsa B., Sinha U. K. Relationships between stem cells and cancer stem cells // Histol Histopathol. -2004. - Vol. 19. - P. 505-509.
Daley G. Q. Common themes of dedifferentiation in somatic cell reprogramming and cancer // Cold Spring Harb Symp Quant Biol. - 2008. - Vol. 73. - P. 171-174.
Diehn M., Cho R. W., Clarke M. F. Therapeutic Implications of the Cancer Stem Cell Hypothesis // Semin Radiat Oncol. - 2009. - Vol. 19. - N. 2. - P. 78-86.
Fabian A., Vereb G., Szollosi J. The Hitchhikers Guide to Cancer Stem Cell Theory: Markers, Pathways and Therapy // Cytometry Part A. - 2013. - Vol. 83A. - P. 62-71.
Floor S., van Staveren W. C., Larsimont D. et al. Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations // Oncogene. - 2011. - Vol. 30. - N. 46. - P. 4609-4621.
Fulawka L., Donizy P., Halon A. Cancer stem cells - the current status of an old concept: literature review and clinical approaches // Biol Res.-2014. - Vol. 47. - P. 66-74.
Gao J. X. Cancer stem cells: the lessons from pre-cancerous stem cells // J Cell Mol Med. - 2008. - Vol. 12. - N. 1. - P. 67-96.
Garvalov B. K., Acker T. Cancer Stem Cells: a New Framework for the Design of Tumor Therapies // J Mol Med. - 2011. - Vol. 89. - P. 95-107.
Geng S., Guo Y, Wang Q. et al. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma // Arch Dermatol Res. - 2013. - Vol. 305. - N. 1. - P. 35-47.
Guan J., Chen J. Mesenchymal stem cells in the tumor microenvironment (Review) // Biomedical reports. - 2013. - Vol. 1. - P. 517 - 521.
Hao J., Zhang Y, Deng M. et al. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells // Int J Cancer. - 2014. - Vol. 135. - N. 5. - P. 1019-1027.
Hill R. P. Identifying Cancer Stem Cells in Solid Tumors: Case Not Proven // Cancer Res - 2006. - Vol. 66. - N. 4. - P. 1891-1896.
Hill R. P., Perris R. “Destemming” Cancer Stem Cells // J Natl Cancer Inst. - 2007. - Vol. 99. - P. 1435-1440.
Hu W-Y., Shi G-B., Hu D-P. et al. Actions of Estrogens and Endocrine Disrupting Chemicals on Human Prostate Stem/Progenitor Cells and Prostate Cancer Risk // Mol Cell Endocrinol. - 2012. - Vol. 354. - N. 1-2. - P. 63-73.
Kasimir-Bauer S., Hoffmann O., Wallwiener W. et al. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells // Breast Cancer Res. - 2012. - Vol. 14. - R15.
Kelly P. N., Dakic A., Adams J. M. et al. Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells // Science. - 2007. - Vol. 317. - P. 337.
Kern S. E., Shibata D. The Fuzzy Math of Solid Tumor Stem Cells: A Perspective // CancerRes. - 2007. - Vol. 67. - N. 19. - P. 8985-8988.
Kondo T. Stem cell-like cancer cells in cancer cell lines // Cancer Biomark. - 2007. - Vol. 3. - N. 4-5. - P. 245-250.
Kong D., Banerjee S., Ahmad A. et al. Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells // PLoS ONE. - 2010. - Vol. 5. - N. 8. - P. e12445.
Kong D., Li Y, Wang Z., Sarkar F. H. Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Pheno-typic Cells: Are They Cousins or Twins? // Cancers. - 2011. - Vol. 3. - P. 716 - 729.
Kreso A., Dick J. E. Evolution of the Cancer Stem Cell Model // Cell Stem Cell. - 2014. - Vol. 14. - P. 275-291.
La Fleur L., Johansson A.-C., Roberg K. A CD44high/ EGFRlow Subpopulation within Head and Neck Cancer Cell Lines Shows an Epithelial-Mesenchymal Transition Phenotype and Resistance to Treatment / PLoS One. - 2012. - Vol. 7. - N. 9. - P. e44071.
Lauth M., Toftgârd R. The Hedgehog pathway as a drug target in cancer therapy // Curr Opin Investig Drugs. -2007. - Vol. 8. - N. 6. - P. 457-461.
Leirös G. J., Balana M. E. Metastatic cancer stem cells: new molecular targets for cancer therapy // Curr Pharm Biotechnol. - 2011. - Vol. 12. - N. 11. - P. 1909-1922.
Li F., Tiede B., Massague J., Kang Y Beyond tumorigenesis: cancer stem sells in metastasis // Cell Res. - 2007. - Vol. 17. - P. 3 - 14.
Li L., Neaves W. B. Normal Stem Cells and Cancer Stem Cells: The Niche Matters // Cancer Res. - 2006. -Vol. 66. - N. 9. - P. 4553-4557.
Lingala S., Cui Y-Y, Chen X. et al. Immunohistochemical Staining of Cancer Stem Cell Markers in Hepatocellular Carcinoma // Exp Mol Pathol. - 2010. - Vol. 89. - N. 1. - P. 27-35.
Mani S. A., Guo W., Liao M.-J. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells // Cell. - 2008. - Vol. 133. - N. 4. - P. 704-715.
Medina V., Calvo M. B., Dfaz-Prado S., Espada J. Hedgehog signalling as a target in cancer stem cells // Clin Transl Oncol. - 2009. - Vol. 11. - N. 4. - P 199-207.
Miller S. J., Lavker R. M., Sun T. T. Interpreting epithelial cancer biology in the context of stem cells: tumor properties and therapeutic implications // Biochim Biophys Acta. - 2005. - Vol. 1756. - N. 1. - P. 25-52.
Ni C., Huang J. Dynamic regulation of cancer stem cells and clinical challenges // Clin Transl Oncol. - 2013. - Vol. 15. - N. 4. - P 253-258.
Polyak K., Weinberg R. A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits // Nat Rev Cancer. - 2009. - Vol. 9. - N. 4. - P. 265-273.
Rapp U. R., Ceteci F., Schreck R. Oncogene-induced plasticity and cancer stem cells // Cell Cycle. - 2008. -Vol. 7. - N. 1. - P 45-51.
Salm S. N., Burger P E., Coetzee S. et al. TGF-b maintains dormancy of prostatic stem cells in the proximal region of ducts // J Cell Biol. - 2005. - Vol. 170. - N. 1. - P. 81-90.
Sell S. Stem cell origin of cancer and differentiation therapy // Crit Rev Oncol Hematol. 2004. - Vol. 51. - N. 1. - P. 1-28.
Sneddon J. B., Werb Z. Location, Location, Location: The Cancer stem Cell Niche // Cell Stem Cell. - 2007. - Vol. 1. - P. 607-611.
Takebe N., Harris P J., Warren R. Q., Ivy S. P. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways // Nat Rev Clin Oncol. - 2011. - Vol. 8. - N. 2. - P. 97-106.
Vezzoni L., Parmiani G. Limitations of the cancer stem cell theory // Cytotechnology. - 2008. - Vol. 58. - P. 3-9.
Xia H., Hui K. M. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics // Cancer Gene Therapy. - 2012. - Vol. 19. - P 723-730.
Zardawi S. J., O’Toole S. A., Sutherland R. L., Musgrove E. A. Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer // Histol Histopathol. - 2009. - Vol. 24. - N. 3. - P. 385-398.
Zhang H., Wang Z. Z. Mechanisms that mediate stem cell self-renewal and differentiation // J Cell Biochem. - 2008. - Vol. 103. - N. 3. - P 709-718.
Zhang P., Zuo H., Ozaki T. et al. Cancer stem cell hypothesis in thyroid cancer // Pathol Int. - 2006. - Vol. 56. - N. 9. - P. 485-489.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...